Navigation Links
Whistleblower's Attorney Says Pfizer's Guilty Plea Today Opens New Chapter on Aggressive Enforcement of Pharma Companies
Date:10/16/2009

WASHINGTON, Oct. 16 /PRNewswire/ -- Pfizer Inc., through a wholly owned subsidiary, is expected to plead guilty to a felony today in federal district court in Boston as part of a plea agreement that includes a record-breaking $1.3 billion criminal fine for the illegal marketing of the painkiller Bextra for unsafe and unapproved uses.

"This case exposed the total disregard a pharmaceutical company had for patients' lives by putting profits above all else," said Erika A. Kelton, a Washington, DC, attorney with Phillips & Cohen LLP, which represented the whistleblower who exposed Pfizer's "off-label" marketing of Bextra. "Pfizer created a corporate culture that encouraged and rewarded those who ignored federal safety laws to boost sales. It took an insider to bring these violations to light and dedicated government officials to stop them."

The federal government lays out details of Pfizer's sales and marketing tactics and strategy for Bextra in a sentencing memorandum, which is posted at http://www.phillipsandcohen.com/CM/NewsSettlements/U.S.Sentencing%20Memo%20re%20Pfizer%20(00015260).PDF

Pfizer's plea agreement was announced Sept. 2 as part of a record $2.3 billion settlement with the federal government, but it has to be approved by the court. In addition to the $1.3 billion criminal fine, Pfizer paid $502 million to the federal government to settle the whistleblower lawsuit brought by Phillips & Cohen that first revealed Pfizer's off-label marketing of Bextra. The remainder of the settlement covered five other "qui tam" lawsuits involving different drugs.

It was the largest criminal fine of any kind imposed in the U.S., the largest healthcare fraud settlement and the largest ever civil fraud settlement against a pharmaceutical company.

"The unprecedented size of the fine certainly shows the government is ratcheting up enforcement involving prescription drugs to protect patients and the Medicare program," Kelton said. "This is great news for whistleblowers, the public and the U.S. Treasury."

Kelton noted that today's outcome was possible only through the work of dedicated and talented government attorneys and staff, in particular Assistant U.S. Attorney Sara Bloom and Assistant U.S. Attorney Susan Poswistilo, both with the U.S. Attorney's office in Boston; Justice Department Trial Attorney Sanjay Bhambhani; and the National Medicaid Fraud Control Units team, headed by Massachusetts Assistant Attorney General Robert Patten.

About Phillips & Cohen LLP

Phillips & Cohen LLP is the nation's most successful law firm representing whistleblowers. "Qui tam" lawsuits brought by Phillips & Cohen have resulted in civil and criminal recoveries totaling $5.3 billion. The firm's attorneys are regularly recognized for their successful work on whistleblower cases with inclusion on such select lists as the Top 10 "Winning Attorneys" in the U.S., the "100 Most Influential Lawyers" and the National Law Journal's "Hot List" of plaintiffs' law firms, most recently for 2009.

SOURCE Phillips & Cohen LLP


'/>"/>
SOURCE Phillips & Cohen LLP
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee
2. Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release
3. Potential Skin Cancer Breakthrough Tested at Scottsdale Healthcare Published Today in New England Journal of Medicine
4. Vtech(R) Delivers Todays Hottest Trends to Tech-Savvy Kids
5. University of Redlands Student Cody Unser Documentary Run to Start Today in L.A.
6. Dendreon to Hold a Conference Call Today at 9:00 AM ET to Provide an Update on Interim Results of Phase 3 PROVENGE IMPACT Trial
7. Calabar AB Today Announced New Financing for Continuation of the Phase II Program in Patients With Dry Mouth
8. TorreyPines Therapeutics to Host Webinar at 11 a.m. EDT Today on the Opportunity for Treating Chronic Pain, Migraine and Muscle Spasticity Through Inhibition of Neurotransmitter Glutamate
9. Phase 1 & 2 Data of Perifosine (KRX-0401) in Patients with Advanced Renal Cell Carcinoma Presented Today at the 25th Annual Chemotherapy Foundation Symposium
10. 454 Sequencing(TM) in Science Today: Researchers Uncover a Genetic Basis for Different Social Behaviors in Wasps
11. TCP Innovations Opens First US Office
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)...  VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) reported ... required to build a strong and stable market for ... on the OTC Markets-pink current trading platform. ... are seeing an anomaly in market trading activities that ... the Company, but shareholders and market players as well. ...
(Date:6/24/2016)... SAN FRANCISCO, Calif. , June 24, 2016 ... GBT ), a biopharmaceutical company developing novel therapeutics ... significant unmet needs, today announced the closing of ... shares of common stock, at the public offering ... shares in the offering were offered by GBT. ...
(Date:6/24/2016)... ALEXANDRIA, Va. , June 24, 2016 ... a set of recommendations that would allow ... information (HCEI) with entities that make formulary and coverage ... determine the "value" of new medicines. The ... that does not appear on the drug label, a ...
Breaking Medicine Technology:
(Date:6/25/2016)... Beach, CA (PRWEB) , ... June 25, 2016 , ... ... UCLA with Magna Cum Laude and his M.D from the David Geffen School of ... Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at the ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van ... Wellness at Work award to iHire in recognition of their exemplary accomplishments in worksite ... 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum ...
(Date:6/24/2016)... Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... surgery procedures that most people are unfamiliar with. The article goes on to state ... procedures, but also many of these less common operations such as calf and cheek ...
(Date:6/24/2016)... ... , ... June 19, 2016 is World Sickle Cell Observance Day. In an ... of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a ... Cell Disease (SCD) is a disorder of the red blood cells, which can cause ...
(Date:6/24/2016)... Texas (PRWEB) , ... June 24, 2016 , ... ... International Conference and Scientific Sessions in Dallas that it will receive two significant ... of the grants came as PHA marked its 25th anniversary by recognizing patients, ...
Breaking Medicine News(10 mins):